Moderna forecasts weaker sales as COVID vaccine demand wanes - National
Moderna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines.
Source: globalnews.ca
📰 Oderna Earnings News
Oderna Earnings News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Oderna Earnings. Real-time updates on events, politics, business and more.
Moderna Q1 Profit, Revenues Down, Yet Beats Market; Backs FY23 COVID-19 Vaccine Sales View
Covid vaccine maker Moderna, Inc. (MRNA) reported Thursday that its first-quarter net income plunged to $79 million from last year's $3.66 billion. Earnings per share were $0.
Source: rttnews.com